Technology Development Board (TDB) signs MoU with M/s Peptris Technologies Pvt. Ltd. and FNDR, Bengaluru

Recently, Technology Development Board (TDB) has signed an MoU with M/s Peptris Technologies Private Limited and Foundation for Neglected Disease Research (FNDR), Bengaluru.

Main points

• Under this agreement, the Board has approved a grant of Rs 75 lakh for the project “ANAGRANINF – Development of a new class of antibiotics for Gram-negative bacterial infections”, while the total project cost is Rs 1.5 crore.
• The project is a joint effort between companies from India and Spain, with ABAC Therapeutics SL acting as the Spanish project lead.
• It aims to promote market-driven research and technology development by promoting partnerships and trade-based collaborative projects between the two countries, thereby leading to innovation in the healthcare sector.
• The primary objective of this project is to develop a novel lead compound specifically containing an antibiotic.
• The goal of this project is to identify a competitor that ensures a new chemical structure while meeting the World Health Organization (WHO) innovation criteria and avoids any conflict with existing commercial classes and to develop a new target and ensure a new mechanism of action.

Technology Development Board (TDB)

• Formation – March 2000
• The board consists of 11 board members.
• The Technology Development Board is a statutory body established by the Government of India under the Technology Development Board Act, 1995.
• It promotes technology development and commercialization and adaptation of imported technology for wider application.

FAQs

Click here to read this article in Hindi.